Monitoring9 min readUpdated 2025-04-03

    GLP-1 Body Measurements: Complete Guide to Tracking Inches Lost

    Learn how to take accurate body measurements while on GLP-1 medications. Track waist, hips, arms, thighs, and chest to see the full picture of your semaglutide or tirzepatide results.

    Inches Tell the Whole Story

    Many semaglutide and tirzepatide patients drop 2-3 clothing sizes before the scale reflects their transformation. Body measurements capture progress that weight alone misses.

    Measurement Sites and Techniques

    Chest/Bust

    Measure at the fullest point, tape level around the back. Keep arms at your sides. Women should wear a consistent bra style or no bra for each measurement.

    Waist

    Measure at the narrowest point between ribs and hips, usually at or slightly above the navel. Exhale normally, don't suck in. This is the most important health-related measurement.

    Hips

    Measure at the widest point of the buttocks. Stand with feet together. Use a mirror to ensure the tape is level from front to back.

    Upper Arms

    Measure the fullest part of the upper arm, halfway between shoulder and elbow. Arm relaxed at your side. Measure both arms and record the average.

    Thighs

    Measure the fullest part of the upper thigh, just below the groin. Stand with weight evenly distributed. Measure both legs and average them.

    Neck

    Measure at the base of the neck, just above the collar bones. This measurement correlates with sleep apnea risk and often decreases significantly with GLP-1 treatment.

    Typical Inches Lost by Timeline

    5-10"
    Total inches lost in first 3 months (all sites combined)
    10-18"
    Total inches lost by 6 months
    15-30+"
    Total inches lost by 12 months

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual results vary significantly. Consult your healthcare provider for personalized treatment guidance.

    Frequently Asked Questions

    How many body measurements should I track on GLP-1?

    At minimum, track waist and hips. For a complete picture, add chest, upper arms, thighs, and neck. Five to seven measurement sites give a comprehensive view of where you're losing inches on semaglutide or tirzepatide.

    How often should I take body measurements?

    Every 2-4 weeks is ideal. Weekly measurements can show too much variation from water retention and bloating. Monthly measurements provide the clearest trends and most motivating comparisons.

    Why am I losing inches but not weight?

    This is actually great news -- it means you're likely losing fat while preserving or building muscle. Muscle is denser than fat, so you can shrink in size without the scale changing. This body recomposition is a sign of healthy weight loss.

    What tools do I need for accurate body measurements?

    A flexible cloth or fiberglass measuring tape (not metal). Measure against bare skin or thin clothing. A mirror helps ensure the tape is level. Some patients find it helpful to have a partner assist for back measurements.

    Start Losing Inches with GLP-1 Treatment

    Compounded semaglutide from $99/mo or tirzepatide from $125/mo.

    View Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: November 24, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Learn the best techniques for taking GLP-1 weight loss progress photos. Consistent lighting, angles, and timing help you accurately track semaglutide and tirzepatide results.

    Learn how to accurately measure your waist circumference while on GLP-1 medications. Waist measurements often show progress before the scale on semaglutide or tirzepatide.

    Know the critical warning signs while on GLP-1 medications. Learn when to call your doctor, visit the ER, or stop semaglutide or tirzepatide. Your safety guide for GLP-1 treatment.

    Create a comprehensive monthly GLP-1 progress report. Compile weight trends, side effects, measurements, and lab results to optimize your semaglutide or tirzepatide treatment.

    Start your GLP-1 journey — from $99/mo

    Get Started